Free Trial
NASDAQ:RDHL

Redhill Biopharma (RDHL) Stock Price, News & Analysis

Redhill Biopharma logo
$1.34 +0.01 (+0.75%)
Closing price 08/28/2025 03:46 PM Eastern
Extended Trading
$1.35 +0.01 (+0.75%)
As of 04:04 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Redhill Biopharma Stock (NASDAQ:RDHL)

Key Stats

Today's Range
$1.29
$1.36
50-Day Range
$1.16
$2.42
52-Week Range
$1.06
$12.50
Volume
18,413 shs
Average Volume
121,416 shs
Market Capitalization
$3.08 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive RDHL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Redhill Biopharma and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

RDHL Stock News Headlines

Man Who Called Nvidia at $1.10 Says Buy This Now...
In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new company could become the next to soar like Nvidia.tc pixel
See More Headlines

RDHL Stock Analysis - Frequently Asked Questions

Redhill Biopharma's stock was trading at $6.21 on January 1st, 2025. Since then, RDHL shares have decreased by 78.4% and is now trading at $1.34.

Redhill Biopharma Ltd. (NASDAQ:RDHL) released its quarterly earnings results on Tuesday, November, 30th. The biotechnology company reported ($500.00) earnings per share (EPS) for the quarter, missing the consensus estimate of ($480.00) by $20.00. The biotechnology company earned $21.61 million during the quarter, compared to the consensus estimate of $23.41 million.

Redhill Biopharma shares reverse split on the morning of Tuesday, August 20th 2024.The 1-25 reverse split was announced on Friday, August 16th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Monday, August 19th 2024. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

Shares of RDHL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Redhill Biopharma investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Adobe (ADBE), Broadcom (AVGO), CymaBay Therapeutics (CBAY) and AbbVie (ABBV).

Company Calendar

Last Earnings
11/30/2021
Today
8/29/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:RDHL
Previous Symbol
ASX:RDH
CIK
1553846
Employees
210
Year Founded
2009

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.54
Quick Ratio
0.37

Sales & Book Value

Annual Sales
$8.04 million
Price / Sales
0.38
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($3.66) per share
Price / Book
-0.37

Miscellaneous

Outstanding Shares
2,300,000
Free Float
2,139,000
Market Cap
$3.08 million
Optionable
No Data
Beta
4.18

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:RDHL) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners